| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 2 |
| 1 | FOSCARBIDOPA/FOSLEVODOPA | 2 |
| 2 | INFLIXIMAB | 2 |
| 3 | PREGABALIN | 2 |
| 4 | VUTRISIRAN | 2 |
| 5 | ACETAMINOPHEN | 1 |
| 6 | ACETAMINOPHEN 500MG | 1 |
| 7 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 1 |
| 8 | ALCOHOL | 1 |
| 9 | APREMILAST | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SERDEXMETHYLPHENIDATE AND DEXMETHYLPHENIDATE | 1 | 0.0013 |
| 1 | COAGULATION FACTOR IX RECOMBINANT HUMAN | 1 | 0.0009 |
| 2 | VUTRISIRAN | 2 | 0.0007 |
| 3 | TRASTUZUMAB-ANNS | 1 | 0.0007 |
| 4 | ELAGOLIX | 1 | 0.0003 |
| 5 | FOSCARBIDOPA/FOSLEVODOPA | 2 | 0.0002 |
| 6 | BEVACIZUMAB-AWWB | 1 | 0.0002 |
| 7 | TAFAMIDIS MEGLUMINE | 1 | 0.0002 |
| 8 | CILTACABTAGENE AUTOLEUCEL | 1 | 0.0002 |
| 9 | CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | B Lymphocyte Stimulator-specific Inhibitor [EPC] | 1 | 0.0000 |
| 1 | Interleukin-17A Antagonist [EPC] | 1 | 0.0000 |
| 2 | Estrogen Receptor Antagonist [EPC] | 1 | 0.0000 |
| 3 | beta3-Adrenergic Agonist [EPC] | 1 | 0.0000 |
| 4 | Tetracycline-class Drug [EPC] | 1 | 0.0000 |
| 5 | HER2/neu Receptor Antagonist [EPC] | 1 | 0.0000 |
| 6 | gamma-Aminobutyric Acid-ergic Agonist [EPC] | 1 | 0.0000 |
| 7 | Phosphodiesterase 4 Inhibitor [EPC] | 1 | 0.0000 |
| 8 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 1 | 0.0000 |
| 9 | Mood Stabilizer [EPC] | 1 | 0.0000 |